Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleInternational PPB/DICER1 Registry
- Where
- Minneapolis
- Age
- 0 Minutes to 100 years
- People
- 3,400
- Run by
- Children's Hospitals and Clinics of Minnesota
See details and how to joinNCT03382158 - Phase 2Taking peopleCobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Where
- Baltimore, Boston, Dallas, Houston, Little Rock, Madison, Memphis, New York, Orange, Phoenix, San Francisco, Washington D.C.
- People
- 90
- Run by
- Carl Allen
See details and how to joinNCT04079179 - Phase 1Taking peopleA Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
- Where
- Atlanta, Boston, Cincinnati, Los Angeles, New York
- Age
- 1 year to 21 years
- People
- 50
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04928677 - Phase 1/2Taking peopleCD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
- Where
- Bethesda
- Age
- 3 years to 39 years
- People
- 130
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05442515 - No phaseTaking peopleHeuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
- Where
- Kansas City, Richmond, Salt Lake City, Seattle
- Age
- 15 years to 29 years
- People
- 126
- Run by
- Virginia Commonwealth University
See details and how to joinNCT05958316 - Phase 2Taking peopleCord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Where
- Seattle
- Age
- 6 months to 65 years
- People
- 54
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06013423 - Phase 1/2Taking peopleGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Where
- Chapel Hill, Columbus, Denver, Duarte, Houston, Jacksonville, Los Angeles, Nashville, Portland, Rochester, Valhalla
- Age
- 13 years to 90 years
- People
- 32
- Run by
- Vironexis Biotherapeutics Inc.
See details and how to joinNCT06533579 - Phase 2Taking peopleCD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Where
- Bethesda
- Age
- 3 years to 65 years
- People
- 20
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07328503 - No phaseTaking peopleAdding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
- Where
- Rochester, Scottsdale
- Age
- 15 years and over
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT07856394 - No phaseTaking peopleInternational Ovarian & Testicular Stromal Tumor Registry
- Where
- Minneapolis
- People
- 500
- Run by
- Children's Hospitals and Clinics of Minnesota
See details and how to joinNCT01970696 - Phase 2Taking peopleObinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- Where
- Valhalla
- Age
- 3 years to 31 years
- People
- 25
- Run by
- New York Medical College
See details and how to joinNCT02393157 - Phase 2Taking peopleAlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Where
- Valhalla
- Age
- 1 day to 30 years
- People
- 20
- Run by
- Mitchell Cairo
See details and how to joinNCT04099966 - Phase 2Taking peopleA Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Where
- Atlanta, Basking Ridge, Boston, Chicago, Cincinnati, Commack, Fort Worth, Harrison, Los Angeles, Middletown, Montvale, New York, Palo Alto, Rockville Centre, St Louis, Washington D.C.
- Age
- 12 months and over
- People
- 45
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05985161 - No phaseEnrolling by invitationFollow-Up for Study Participants Treated With an Allogeneic CAR T Cell Product
- Where
- Buffalo
- People
- 50
- Run by
- Allogene Therapeutics
See details and how to joinNCT06925685 - Phase 1Taking peopleA Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Chicago, Cincinnati, Houston, Indianapolis, Memphis, Minneapolis, New York, Philadelphia, Pittsburgh, San Francisco, Seattle
- Age
- Up to 21 years
- People
- 47
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07012044 - Phase 1/2Taking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Chapel Hill, Decatur, Durham, Houston, New York, Portland
- Age
- 16 years and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - No phaseNot yet taking people in United StatesWeight Gain in Pediatric Leukemia Survivors
- Where
- St Louis
- Age
- 6 years and over
- People
- 80
- Run by
- Washington University School of Medicine
See details and how to joinNCT07374315 - No phaseTaking peopleThe NF Registry Sponsored by the Children's Tumor Foundation
- Where
- New York
- People
- 20,000
- Run by
- The Children's Tumor Foundation
See details and how to joinNCT01885767 - No phaseTaking peopleCollection and Storage of Tissue and Blood Samples From Patients With Cancer
- Where
- Ann Arbor, Arroyo Grande, Auburn, Augusta, Aurora, Bainbridge Island, Baltimore, Battle Creek, Birmingham, Bloomington, Bolivar, Bonne Terre, Boston, Branson, Canton, Cape Girardeau, Carbondale, Carthage, Centralia, Chanute, Chapel Hill, Chicago, Chippewa Falls, Decatur, Dodge City, Duarte, Durham, Eau Claire, Effingham, El Dorado, Eureka, Federal Way, Fort Scott, Fort Smith, Galesburg, Gig Harbor, Grand Rapids, Henderson, Houston, Independence, Jefferson City, Joplin, Kalamazoo, Kewanee, Kingman, La Crosse, Las Vegas, Lawrence, Liberal, Livonia, Los Angeles, Lynnwood, Macomb, Manhattan, Marshfield, Memphis, Minocqua, Mount Vernon, Muskegon, Newark, New Haven, Newton, New York, Niles, O'Fallon, Oklahoma City, Ottawa, Oxford, Parsons, Pekin, Peoria, Peru, Pratt, Princeton, Puyallup, Reed City, Rice Lake, Rochester, Rolla, Sainte Genevieve, Saint Joseph, Salina, Seattle, Springfield, Stevens Point, St Louis, Sullivan, Tacoma, The Bronx, Traverse City, Wausau, Wellington, Weston, Wichita, Wilmington, Winfield
- Age
- 2 months and over
- People
- 5,000
- Run by
- National Cancer Institute LAO
See details and how to joinNCT02474160 - No phaseTaking peopleMaternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
- Where
- Camden
- People
- 400
- Run by
- Cooper Norcross Health
See details and how to joinNCT02749474 - No phaseTaking peopleChangeGradients: Promoting Adolescent Health Behavior Change
- Where
- San Francisco
- Age
- 15 years to 17 years
- People
- 200
- Run by
- University of California, San Francisco
See details and how to joinNCT04110756 - Phase 1Taking peopleStudy of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Where
- Atlanta, Aurora, Cincinnati, Dallas, Fort Worth, Kansas City, Memphis, New York, Philadelphia, San Diego
- Age
- 1 year to 30 years
- People
- 24
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06177067 - No phaseTaking peopleImproving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
- Where
- Hartford
- Age
- 15 years to 25 years
- People
- 60
- Run by
- Connecticut Children's Medical Center
See details and how to joinNCT06982066 - No phaseNot yet taking people in United StatesReal World Asparaginase Therapy Toxicity
- Where
- Memphis
- People
- 200
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07008027 - No phaseEnrolling by invitationBiology Studies of Hematologic Cancers
- Where
- Bethesda
- Age
- 1 year to 120 years
- People
- 550
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00923442